lntradermal heparin sodium cost-effective and less-invasive treatment than CO2 laser for early mild xanthelasma
Xanthelasma, characterized by yellowish cholesterol deposits around the eyelids, often necessitates therapeutic interventions. Ablative CO2 laser treatment is a common approach, yet associated complications warrant exploration of alternative therapies. Recently, intradermal heparin sodium injections emerged as a potential treatment. A study compares the efficacy of CO2 laser versus heparin sodium injections in managing xanthelasma lesions. This study was published in the journal Photodermatology, Photoimmunology and Photomedicine by Yomna M. and colleagues.
- CO2 Laser vs. Heparin Sodium:
A pilot study involving 30 xanthelasma patients divided into two groups:
Group A underwent CO2 laser ablation (2 sessions every 4 weeks).
Group B received intradermal heparin sodium injections (10 sessions every week).
- Therapeutic Efficacy:
Both interventions exhibited significant reduction in xanthelasma lesions.
CO2 laser treatment was notably more effective than intradermal heparin sodium overall.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.